HomeVRTX • NASDAQ
Vertex Pharmaceuticals Inc
add
$421.16
2.51%
Pre-market:(0.51%)-2.16
$419.00
Closed: May 15, 6:06:38 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.77B | 2.96% |
Operating expense | 396.40M | 15.67% |
Net income | 646.30M | -41.22% |
Net profit margin | 23.33 | -42.92% |
Earnings per share | 4.06 | -14.71% |
EBITDA | 1.08B | -14.98% |
Effective tax rate | 11.51% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.20B | -39.03% |
Total assets | 22.88B | -4.34% |
Total liabilities | 6.38B | 18.87% |
Total equity | 16.50B | — |
Shares outstanding | 256.80M | — |
Price to book | 6.73 | — |
Return on assets | 11.35% | — |
Return on capital | 14.20% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 646.30M | -41.22% |
Cash from operations | 818.90M | -37.33% |
Cash from investing | -55.80M | 97.39% |
Cash from financing | -680.40M | -90.32% |
Net change in cash | 113.20M | 109.41% |
Free cash flow | 800.16M | -10.23% |
Previous close
$432.00
Day range
$416.60 - $433.41
Year range
$378.00 - $519.88
Market cap
108.15B USD
Avg Volume
2.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
Founded
1989
Headquarters
Website
Employees
6,100
